Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rebecca Yee Bassett"'
Autor:
Windy Berkofsky-Fessler, Constance Murphy, Deborah Pencarinha, Jessica K. Booker, Rebecca Yee Bassett, Haiyan Wan, Mingjuan Liao, Melanie Hussong, Nina Sanapareddy, Elisabeth McKeen, Kathleen S. Hruska, Patricia D. Murphy, Rachel Nusbaum, Erica S. Rinella, Rachel T. Klein, Zhixiong Xu, Joaquin Villar, Lisa R. Susswein, Maria L Cremona
Publikováno v:
Cancer Research. 75:P4-12
Introduction: Expansion of genetic testing technologies has brought multi-gene panels for cancer susceptibility into the clinic; however, the clinical utility of these next-generation sequencing (NGS) panels is largely unknown. Hypothesis: We hypothe
Autor:
Leslie R. Boyd, Katherine J. Sapra, Rachelle Lorenz Chambers, Stephanie V. Blank, John P. Curtin, Bhavana Pothuri, Melissa K. Frey, Sarah H. Kim, Jessica Martineau, Rachel Sobolev, Gabriella Sandler, Rebecca Yee Bassett
Publikováno v:
Gynecologic oncology. 146(1)
Objective To evaluate the results of multigene panel testing among Ashkenazi Jewish compared with non-Ashkenazi Jewish patients. Methods We reviewed the medical records for all patients who underwent multigene panel testing and targeted BRCA1/2 testi
Autor:
Stephanie V. Blank, Jessica Martineau, Melissa K. Frey, Sarah H. Kim, Rebecca Yee Bassett, Jing-Yi Chern, Emily Dalton
Publikováno v:
Gynecologic oncology. 139(2)
Objective The availability of next-generation sequencing and identification of multiple cancer-related genes has caused a shift away from single gene testing towards multi-gene panel testing for hereditary cancer syndromes. However, the utility of pa
Autor:
Jessica Martineau, Sarah H. Kim, Melissa K. Frey, Rachel Sobolev, Rachelle Lorenz Chambers, G. Sandler, Rebecca Yee Bassett, Stephanie V. Blank
Publikováno v:
Gynecologic Oncology. 141:10
Autor:
Jing-Yi Chern, Sarah S. Lee, Melissa K. Frey, Rebecca Yee Bassett, Stephanie V. Blank, Jessica Martineau
Publikováno v:
Journal of Clinical Oncology. 33:1555-1555
1555 Background: Among patients undergoing genetic testing for BRCA1/2 mutations, 7% will harbor a variant of uncertain significance (VUS), a finding with more emotional than clinical weight. The o...
Publikováno v:
Journal of Clinical Oncology. 33:1536-1536
1536 Background: The availability of next-generation sequencing coupled with the recent discovery of multiple cancer-related genes has caused a shift away from single gene testing towards multi-gene panel testing for familial cancer syndromes. Howeve